Mural Oncology Plc (MURA)

$1.76 -0.01 (-0.56%)
Market Cap 30.66M
Revenue (ttm) 0.00
Net Income (ttm) -128.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 82,700
Avg Vol 169,612
Day's Range N/A - N/A
Shares Out 17.32M
Stochastic %K 74%
Beta 3.00
Analysts Sell
Price Target $9.50

Company Profile

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tu...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 905 8020
Address:
10 Earlsfort Terrace, Dublin, Ireland
buyandsold
buyandsold Aug. 14 at 6:05 AM
$MURA $30M wind down, why shares so high?
1 · Reply
zamped1
zamped1 Aug. 13 at 9:02 PM
$MURA I like what what I see the last 2 days. ..LUCID FINANCIAL does crypto and if this happens..boom time...rusk/reward could be monumental...
0 · Reply
dd101go
dd101go Aug. 9 at 6:24 AM
$MURA over $4/share cash for under $2, real world is different from market, a Big sale sign would be out front
1 · Reply
inelegantinvest
inelegantinvest Aug. 5 at 11:28 AM
🎨 Another one bites the dust: Mural Oncology $MURA will wind down after nemvaleukin alfa fails in the clinic. 💸 From $275M to <$50M in under 2 years. 🧾 Shareholders may get < $2/share. Full story → https://stockspinoffs.com/2025/08/05/mural-oncology-paints-itself-into-a-corner-after-nemvaleukin-alfa-fails/ $ALKS
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 6:38 PM
$MURA just stumbled -7% lower to -25% (~883Kv) in the last few minutes, 08/15 options, follow for more volatility.
0 · Reply
Sswerve
Sswerve Aug. 4 at 4:10 PM
$MURA 😂🤣😂😂😂
0 · Reply
gilheydari
gilheydari Aug. 4 at 3:27 PM
$MURA They wasted a lot of cash!
0 · Reply
Crapmaster2000
Crapmaster2000 Aug. 1 at 3:29 PM
$MURA the volume has been going up on this over the last two days. The average volume for July was under 90k and today only two hours in and we are at 130k already. I was on Stocktwits posting about VOR about a month before it took off from $ .20/share. Keep an eye on this one I am thinking a merger / acquisition happens before earnings this month!
1 · Reply
Crapmaster2000
Crapmaster2000 Jun. 30 at 6:47 PM
$MURA has anyone heard any update on what's going on with this stock lately?
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Jun. 3 at 6:58 PM
$MURA HEY LIVERMORE..How about reading more and posting less..In Ireland, wind-down plans, which outline how a company or institution would be wound down in an orderly manner, are governed by various regulations, including the Companies Act 2014 and guidance from the Central Bank of Ireland. These plans are crucial for minimizing disruption and ensuring the fair treatment of stakeholders in the event of failure.
0 · Reply
Latest News on MURA
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Aug 4, 2025, 8:00 AM EDT - 12 days ago

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Mural Oncology Announces Number of Relevant Securities in Issue

May 19, 2025, 3:57 PM EDT - 3 months ago

Mural Oncology Announces Number of Relevant Securities in Issue

FORM 8.1(a) & (b) - Mural Oncology plc

Apr 30, 2025, 3:07 PM EDT - 3 months ago

FORM 8.1(a) & (b) - Mural Oncology plc

Mural Oncology Announces Plans to Explore Strategic Alternatives

Apr 15, 2025, 8:00 AM EDT - 4 months ago

Mural Oncology Announces Plans to Explore Strategic Alternatives

Mural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock Plunges

Mar 25, 2025, 9:28 AM EDT - 5 months ago

Mural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock Plunges

Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer

Mar 25, 2025, 6:30 AM EDT - 5 months ago

Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer

Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones

Mar 11, 2025, 4:01 PM EDT - 5 months ago

Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones

Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 7:00 AM EST - 6 months ago

Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts

Jan 9, 2025, 4:00 PM EST - 7 months ago

Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 3, 2024, 4:15 PM EST - 9 months ago

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

Nov 20, 2024, 4:15 PM EST - 9 months ago

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

Mural Oncology to Participate in Two Upcoming Investor Conferences

Nov 11, 2024, 7:00 AM EST - 9 months ago

Mural Oncology to Participate in Two Upcoming Investor Conferences

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Nov 7, 2024, 4:15 PM EST - 10 months ago

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Oct 7, 2024, 7:00 AM EDT - 11 months ago

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

Sep 23, 2024, 7:00 AM EDT - 11 months ago

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Sep 10, 2024, 7:00 AM EDT - 1 year ago

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Mural Oncology to Present at Two Upcoming Investor Conferences

Aug 27, 2024, 7:00 AM EDT - 1 year ago

Mural Oncology to Present at Two Upcoming Investor Conferences

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress

Aug 13, 2024, 7:15 AM EDT - 1 year ago

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

Jun 5, 2024, 4:15 PM EDT - 1 year ago

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

May 14, 2024, 7:00 AM EDT - 1 year ago

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 24, 2024, 4:00 PM EDT - 1 year ago

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Apr 9, 2024, 4:00 PM EDT - 1 year ago

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Mar 26, 2024, 7:00 AM EDT - 1 year ago

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 5, 2024, 4:35 PM EST - 1 year ago

Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value

Mar 3, 2024, 11:53 PM EST - 1 year ago

Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value

Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference

Feb 27, 2024, 7:00 AM EST - 1 year ago

Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference

buyandsold
buyandsold Aug. 14 at 6:05 AM
$MURA $30M wind down, why shares so high?
1 · Reply
zamped1
zamped1 Aug. 13 at 9:02 PM
$MURA I like what what I see the last 2 days. ..LUCID FINANCIAL does crypto and if this happens..boom time...rusk/reward could be monumental...
0 · Reply
dd101go
dd101go Aug. 9 at 6:24 AM
$MURA over $4/share cash for under $2, real world is different from market, a Big sale sign would be out front
1 · Reply
inelegantinvest
inelegantinvest Aug. 5 at 11:28 AM
🎨 Another one bites the dust: Mural Oncology $MURA will wind down after nemvaleukin alfa fails in the clinic. 💸 From $275M to <$50M in under 2 years. 🧾 Shareholders may get < $2/share. Full story → https://stockspinoffs.com/2025/08/05/mural-oncology-paints-itself-into-a-corner-after-nemvaleukin-alfa-fails/ $ALKS
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 6:38 PM
$MURA just stumbled -7% lower to -25% (~883Kv) in the last few minutes, 08/15 options, follow for more volatility.
0 · Reply
Sswerve
Sswerve Aug. 4 at 4:10 PM
$MURA 😂🤣😂😂😂
0 · Reply
gilheydari
gilheydari Aug. 4 at 3:27 PM
$MURA They wasted a lot of cash!
0 · Reply
Crapmaster2000
Crapmaster2000 Aug. 1 at 3:29 PM
$MURA the volume has been going up on this over the last two days. The average volume for July was under 90k and today only two hours in and we are at 130k already. I was on Stocktwits posting about VOR about a month before it took off from $ .20/share. Keep an eye on this one I am thinking a merger / acquisition happens before earnings this month!
1 · Reply
Crapmaster2000
Crapmaster2000 Jun. 30 at 6:47 PM
$MURA has anyone heard any update on what's going on with this stock lately?
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Jun. 3 at 6:58 PM
$MURA HEY LIVERMORE..How about reading more and posting less..In Ireland, wind-down plans, which outline how a company or institution would be wound down in an orderly manner, are governed by various regulations, including the Companies Act 2014 and guidance from the Central Bank of Ireland. These plans are crucial for minimizing disruption and ensuring the fair treatment of stakeholders in the event of failure.
0 · Reply
towerofthemoon
towerofthemoon May. 30 at 10:35 PM
$MURA Omni
0 · Reply
LivermoresGhost
LivermoresGhost May. 29 at 3:44 PM
$MURA I've sees this type company beofre. Look Selecta Bioscience, its fail its IMMTOR program for gene drug redose. The managements have 120 million cash, once give its "retention bonus" and salary, and make the deal, its stay 40 million cash, and all its shareholders wonder where the cash go. This was with Carsten Crooks and "science guy" Timothy Springer. It's trade now like RNAC and continue dilutes, here is stock ticker.
1 · Reply
ATNews
ATNews May. 21 at 4:55 PM
$MURA We dont play around when alerting tickers. Take a look at our discord and never look back
0 · Reply
ATNews
ATNews May. 21 at 4:54 PM
$ICCT $MURA $BULL $XAGE Fox our trader helped up greatly with growing our money. If you want his alerts go check out our discord!
0 · Reply
ATNews
ATNews May. 21 at 4:53 PM
$ICCT $MURA $BULL $XAGE
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING May. 20 at 8:38 PM
$MURA Where oh where have the sisters MWilson and Sswerve gone ??...These 2 short sisters were pounding the table on a "rug pull" at 2.50 weeks ago...C`mon sisters at least be woman enough to admit you were wrong..
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING May. 19 at 8:11 PM
$MURA Where is the "rug pull" below 1 dollar that sswerv and her sister mwilson predicted weeks ago..oh i forgot, they weren`t woman enough to admit they were wrong so changed their prediction to "i got all year to wait"..
0 · Reply
DorunimusMarcelium
DorunimusMarcelium May. 15 at 6:18 PM
$MURA slowly dying.
1 · Reply
AKnewMann
AKnewMann May. 15 at 3:51 PM
$MURA zombie stock, dead money...
0 · Reply
RandySavage
RandySavage May. 15 at 12:02 PM
$MURA hmmmmmm
0 · Reply
amazingcrwns
amazingcrwns May. 14 at 8:35 PM
$MURA I'm not sure what I was expecting, but I was hoping the earnings report would provide some more information.
0 · Reply
ATNews
ATNews May. 14 at 2:16 PM
$MURA
1 · Reply